-
Impact of SR-BI and CD81 on Hepatitis C virus entry and evasion
Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. In the first part of my PhD, we aimed to further characterize the role of... -
Study of the neutralizing antibody response against the hepatitis C virus
Hepatitis C Virus (HCV) is the major etiological agent of liver disease in the world with approximately180 million people who are seropositive. The majority (60‐90%)... -
Characterisation of HCV entry inhibitors
Hepatitis C, whose causal agent is called Hepatitis C Virus (HCV), is a global health burden with about 170 million people infected. Currently, no vaccine exists again... -
Hepatitis C Virus E1E2 co-evolving networks unveil their functional dialogs a...
Hepatitis C Virus (HCV) infects more than 170 million people worldwide but no vaccine is available yet. HCV entry may represent a promising target for therapies and is... -
Type III Phosphatidylinositol 4-kinases in the liver : involvement during Hep...
Hepatitis C virus (HCV) is one of the leading causes of hepatocellular carcinoma. Therapeutic treatment against the virus has been recently improved by a tritherapy...
